These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19552546)

  • 1. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
    Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
    Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine: a potential complexing agent for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Biol; 2010 Jan; 48(1):113-5. PubMed ID: 20645765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation.
    Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW
    Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criterion for excipients screening in the development of nanoemulsion formulation of three anti-inflammatory drugs.
    Shakeel F
    Pharm Dev Technol; 2010; 15(2):131-8. PubMed ID: 19911951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
    Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
    J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical delivery of celecoxib using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib.
    McDonald BF; Coulter IS; Marison IW
    Pharm Dev Technol; 2015 Mar; 20(2):211-8. PubMed ID: 24283499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib.
    Tamilvanan S; Baskar R
    Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying core.
    Homar M; Dreu R; Kerc J; Gasperlin M
    J Microencapsul; 2009 Sep; 26(6):479-84. PubMed ID: 19694601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and in vitro enzymatic stability of newly synthesized celecoxib lipophilic and hydrophilic amides.
    Qandil AM; El Mohtadi FH; Tashtoush BM
    Int J Pharm; 2011 Sep; 416(1):85-96. PubMed ID: 21704141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of microspheres containing low solubility drug compound by electrohydrodynamic spraying.
    Bohr A; Kristensen J; Stride E; Dyas M; Edirisinghe M
    Int J Pharm; 2011 Jun; 412(1-2):59-67. PubMed ID: 21511018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment.
    Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
    J Drug Target; 2008 Dec; 16(10):733-40. PubMed ID: 18985507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of a new self-nanoemulsifying drug delivery system.
    Wang L; Dong J; Chen J; Eastoe J; Li X
    J Colloid Interface Sci; 2009 Feb; 330(2):443-8. PubMed ID: 19038395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.